Skip to content

Umbilical cord mesenchymal stem cell transplantation for treatment of type2 diabetes

Umbilical cord mesenchymal stem cell transplantation for treatment of type2 diabetes

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-10000985
Enrollment
Unknown
Registered
2010-08-04
Start date
2010-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

treatment group:Umbilical cord mesenchymal stem cell transplantation

Sponsors

Armed Police General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. the patients were between the ages of 18 and 70 years, male or female; 2. they had poor blood control with recent anti-diabetic therapies, including drugs and/or insulin injection for at least three months; 3. they had a negative result in testing for the glutamic acid decarboxylase antibody; 4. they had not been pregnant or nursing; 5. they had a fasting blood glucose (FBG) level >=7.0 mmol/L and HbAc1>=7%; 6. they had a good organic sufficiency, including heart, liver, kidney and lung, to receive interventional therapy.

Exclusion criteria

Exclusion criteria: 1. cancer; 2. serious heart disease or hypertension; 3. acute and chronic renal insufficiency or liver failure; 4. severe asthma or other severe respiratory insufficiency; 5. hemorrhagic disease, coagulopathy, contrast agent allergy or are being applied anticoagulant drugs; 6. congenital or acquired immunodeficiency diseases; 7. other endocrine and metabolic diseases.

Design outcomes

Primary

MeasureTime frame
Blood sugar;Glycated hemoglobin;Islet function;Inflammatory cytokines (IL-1beta, IL-6, IL-10 and TNF-alpha);

Secondary

MeasureTime frame
Peripheral blood T lymphocyte subset count;C peptid;

Countries

China

Contacts

Public ContactYihua An
riveran@163.com+86 010-88276849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026